Literature DB >> 26410093

Procedural intervention for arthrofibrosis after ACL reconstruction: trends over two decades.

Thomas L Sanders1, Hilal Maradit Kremers2,3, Andrew J Bryan2, Walter K Kremers3, Michael J Stuart2, Aaron J Krych2.   

Abstract

PURPOSE: Arthrofibrosis is a rare complication after anterior cruciate ligament (ACL) reconstruction. The purpose of this study was to (1) report a population-based incidence of arthrofibrosis (as defined by manipulation under anaesthesia or surgical lysis of adhesions) following ACL injury and reconstruction, (2) identify risk factors associated with development of arthrofibrosis, and (3) report outcomes of intervention for arthrofibrosis.
METHODS: This was a historical cohort study performed in Olmsted County, Minnesota. The Rochester Epidemiology Project (REP) was used to identify a population-based cohort of individuals with new-onset, isolated ACL tears between 1 January 1990 and 31 December 2010. The REP database provides access to all medical records for each resident of Olmsted County, regardless of the facility where the care was delivered. A total of 1841 individuals were identified with new-onset, isolated ACL tears and were confirmed with chart review. The intervention incidence for arthrofibrosis was then calculated, and various predictive factors including age, sex, calendar year, and meniscal injury were investigated.
RESULTS: During follow-up, 5 patients (1.0 %) in the non-operative cohort and 23 patients (1.7 %) in the ACL reconstruction cohort received intervention for arthrofibrosis, corresponding to an incidence of 0.7 per 1000 person-years in the non-operative cohort and 1.9 per 1000 person-years in the ACL reconstruction cohort. Female patients were 2.5 times more likely to have arthrofibrosis than males. The mean preoperative range of motion was -8° to 83° and improved to a mean of -2° to 127° post-operatively.
CONCLUSIONS: Arthrofibrosis remains a rare but potentially devastating complication after ACL reconstruction, and roughly 2 % of patients had post-operative stiffness that required intervention. Female patients are at higher risk of arthrofibrosis. However, when patients develop severe motion complications after ACL injury, interventions are generally effective in preventing permanent arthrofibrosis.

Entities:  

Keywords:  ACL Injury; ACL reconstruction; Arthrofibrosis; Lysis of adhesions; Manipulation; Procedural Intervention

Mesh:

Year:  2015        PMID: 26410093      PMCID: PMC4936949          DOI: 10.1007/s00167-015-3799-x

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  20 in total

1.  Prevention of permanent arthrofibrosis after anterior cruciate ligament reconstruction alone or combined with associated procedures: a prospective study in 443 knees.

Authors:  F R Noyes; S Berrios-Torres; S D Barber-Westin; T P Heckmann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2000       Impact factor: 4.342

2.  Arthrofibrosis following ACL reconstruction--reasons and outcome.

Authors:  Hermann O Mayr; Thomas G Weig; Wolfgang Plitz
Journal:  Arch Orthop Trauma Surg       Date:  2004-08-03       Impact factor: 3.067

3.  The optimal timing for anterior cruciate ligament reconstruction with respect to the risk of postoperative stiffness.

Authors:  Chun Shing Kwok; Tim Harrison; Chris Servant
Journal:  Arthroscopy       Date:  2013-01-12       Impact factor: 4.772

4.  Prevention of arthrofibrosis after anterior cruciate ligament reconstruction using the central third patellar tendon autograft.

Authors:  A J Cosgarea; W J Sebastianelli; K E DeHaven
Journal:  Am J Sports Med       Date:  1995 Jan-Feb       Impact factor: 6.202

5.  Results of arthroscopic treatment of symptomatic loss of extension following anterior cruciate ligament reconstruction.

Authors:  S S Hasan; A Saleem; B R Bach; C A Bush-Joseph; J Bojchuk
Journal:  Am J Knee Surg       Date:  2000

6.  Outcome of surgical treatment of arthrofibrosis following ligament reconstruction.

Authors:  Sinan Said; Svend Erik Christainsen; Peter Faunoe; Bent Lund; Martin Lind
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-03-24       Impact factor: 4.342

7.  Outpatient surgical management of arthrofibrosis after anterior cruciate ligament surgery.

Authors:  K D Shelbourne; G E Johnson
Journal:  Am J Sports Med       Date:  1994 Mar-Apr       Impact factor: 6.202

8.  Postoperative range of motion following anterior cruciate ligament reconstruction using autograft hamstrings: a prospective, randomized clinical trial of early versus delayed reconstructions.

Authors:  Craig R Bottoni; Travis R Liddell; Timothy J Trainor; David M Freccero; Kenneth K Lindell
Journal:  Am J Sports Med       Date:  2008-01-22       Impact factor: 6.202

9.  Arthrofibrosis in acute anterior cruciate ligament reconstruction. The effect of timing of reconstruction and rehabilitation.

Authors:  K D Shelbourne; J H Wilckens; A Mollabashy; M DeCarlo
Journal:  Am J Sports Med       Date:  1991 Jul-Aug       Impact factor: 6.202

Review 10.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.

Authors:  Walter A Rocca; Barbara P Yawn; Jennifer L St Sauver; Brandon R Grossardt; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2012-11-28       Impact factor: 7.616

View more
  29 in total

1.  Cyclops lesions detected by MRI are frequent findings after ACL surgical reconstruction but do not impact clinical outcome over 2 years.

Authors:  Luca Facchetti; Benedikt J Schwaiger; Alexandra S Gersing; Julio Brandao Guimaraes; Lorenzo Nardo; Sharmila Majumdar; Benjamin C Ma; Thomas M Link; Xiaojuan Li
Journal:  Eur Radiol       Date:  2016-12-16       Impact factor: 5.315

2.  Arthroscopic Posteromedial Capsular Release.

Authors:  Chase S Dean; Jorge Chahla; Jacob D Mikula; Justin J Mitchell; Robert F LaPrade
Journal:  Arthrosc Tech       Date:  2016-05-16

3.  Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis.

Authors:  William A Blessing; Stephen M Okajima; M Belen Cubria; Juan C Villa-Camacho; Miguel Perez-Viloria; Patrick M Williamson; Angie N Sabogal; Sebastian Suarez; Lay-Hong Ang; Suzanne White; Evelyn Flynn; Edward K Rodriguez; Mark W Grinstaff; Ara Nazarian
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-03       Impact factor: 11.205

4.  High rate of recurrent patellar dislocation in skeletally immature patients: a long-term population-based study.

Authors:  Thomas L Sanders; Ayoosh Pareek; Timothy E Hewett; Michael J Stuart; Diane L Dahm; Aaron J Krych
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-03-15       Impact factor: 4.342

5.  Young age, female gender, Caucasian race, and workers' compensation claim are risk factors for reoperation following arthroscopic ACL reconstruction.

Authors:  Brian M Capogna; Siddharth A Mahure; Brent Mollon; Matthew L Duenes; Andrew S Rokito
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-12-07       Impact factor: 4.342

6.  Long-term rate of graft failure after ACL reconstruction: a geographic population cohort analysis.

Authors:  Thomas L Sanders; Ayoosh Pareek; Timothy E Hewett; Bruce A Levy; Diane L Dahm; Michael J Stuart; Aaron J Krych
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-08-13       Impact factor: 4.342

7.  Postoperative Serum Cytokine Levels Are Associated With Early Stiffness After Total Knee Arthroplasty: A Prospective Cohort Study.

Authors:  Michael-Alexander Malahias; George A Birch; Haoyan Zhong; Alexandra Sideris; Alejandro Gonzalez Della Valle; Peter K Sculco; Meghan Kirksey
Journal:  J Arthroplasty       Date:  2020-02-28       Impact factor: 4.757

8.  Molecular pathology of human knee arthrofibrosis defined by RNA sequencing.

Authors:  Banu Bayram; Afton K Limberg; Christopher G Salib; Jacob W Bettencourt; William H Trousdale; Eric A Lewallen; Nicolas Reina; Christopher R Paradise; Roman Thaler; Mark E Morrey; Joaquin Sanchez-Sotelo; Daniel J Berry; Andre J van Wijnen; Matthew P Abdel
Journal:  Genomics       Date:  2020-03-05       Impact factor: 5.736

9.  Sustained Delivery of SB-431542, a Type I Transforming Growth Factor Beta-1 Receptor Inhibitor, to Prevent Arthrofibrosis.

Authors:  Andy J Lee; Christopher M Mahoney; Charles C Cai; Rika Ichinose; Robert M Stefani; Kacey G Marra; Gerard A Ateshian; Roshan P Shah; Gordana Vunjak-Novakovic; Clark T Hung
Journal:  Tissue Eng Part A       Date:  2021-05-12       Impact factor: 3.845

10.  Arthrofibrosis following primary total hip arthroplasty: a distinct clinical entity.

Authors:  Thorsten Gehrke; Lara Althaus; Philip Linke; Jochen Salber; Veit Krenn; Mustafa Citak
Journal:  Arch Orthop Trauma Surg       Date:  2021-05-09       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.